Dr. Reddy’s Laboratories Ltd ADR (RDY) — Cash Flow-to-Debt Ratio
Dr. Reddy’s Laboratories Ltd ADR (RDY) has a Cash Flow-to-Debt Ratio of 0.06x as of December 2025, meaning its operating cash flow of $10.91 Billion could theoretically repay 0% of its total liabilities ($187.14 Billion) in one year. See how financially flexible is Dr. Reddy’s Laboratories Ltd ADR to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Dr. Reddy’s Laboratories Ltd ADR Cash Flow-to-Debt Ratio (2000–2025)
Historical debt coverage capacity for Dr. Reddy’s Laboratories Ltd ADR across 26 annual periods. For the full cash flow conversion analysis, see how efficiently does Dr. Reddy’s Laboratories Ltd ADR generate cash.
Annual Cash Flow-to-Debt Ratio for Dr. Reddy’s Laboratories Ltd ADR (2000–2025)
Year-by-year debt coverage analysis for Dr. Reddy’s Laboratories Ltd ADR. Check cash flow quality index of Dr. Reddy’s Laboratories Ltd ADR to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.30x | $46.43 Billion | $155.82 Billion | ▼ -29.8% |
| 2024 | 0.42x | $45.43 Billion | $106.97 Billion | ▼ -34.4% |
| 2023 | 0.65x | $58.87 Billion | $90.86 Billion | ▲ +135.8% |
| 2022 | 0.27x | $28.11 Billion | $102.30 Billion | ▼ -99.0% |
| 2021 | 28.24x | $35.70 Billion | $1.26 Billion | ▼ -3.4% |
| 2020 | 29.22x | $29.84 Billion | $1.02 Billion | ▲ +8576.9% |
| 2019 | 0.34x | $28.70 Billion | $85.23 Billion | ▲ +85.2% |
| 2018 | 0.18x | $18.03 Billion | $99.14 Billion | ▼ -19.0% |
| 2017 | 0.22x | $21.51 Billion | $95.78 Billion | ▼ -56.8% |
| 2016 | 0.52x | $41.25 Billion | $79.31 Billion | ▲ +73.4% |
| 2015 | 0.30x | $25.03 Billion | $83.46 Billion | ▲ +22.4% |
| 2014 | 0.25x | $19.46 Billion | $79.42 Billion | ▲ +1174.6% |
| 2013 | 0.02x | $13.32 Billion | $692.64 Billion | ▼ -92.6% |
| 2012 | 0.26x | $16.15 Billion | $62.03 Billion | ▲ +59.3% |
| 2011 | 0.16x | $8.01 Billion | $49.02 Billion | ▼ -53.8% |
| 2010 | 0.35x | $13.23 Billion | $37.41 Billion | ▲ +227.6% |
| 2009 | 0.11x | $4.50 Billion | $41.75 Billion | ▼ -32.4% |
| 2008 | 0.16x | $6.12 Billion | $38.38 Billion | ▼ -40.1% |
| 2007 | 0.27x | $11.83 Billion | $44.44 Billion | ▲ +651.6% |
| 2006 | 0.04x | $1.65 Billion | $46.50 Billion | ▼ -87.1% |
| 2005 | 0.27x | $2.29 Billion | $8.34 Billion | ▼ -61.6% |
| 2004 | 0.72x | $4.01 Billion | $5.59 Billion | ▼ -30.1% |
| 2003 | 1.03x | $4.35 Billion | $4.25 Billion | ▼ -22.7% |
| 2002 | 1.33x | $4.65 Billion | $3.51 Billion | ▲ +1323.6% |
| 2001 | 0.09x | $614.87 Million | $6.60 Billion | ▼ -63.7% |
| 2000 | 0.26x | $14.29 Million | $55.70 Million | — |